Achilles Therapeutics

1.13
-0.01 (-0.88%)
At close: Jan 28, 2025, 1:52 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.51 -0.49 -2.35 -20.25 -1.94 -1.3
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 0.25 0.18 0.50 3.55 0.27 0.71
P/FCF Ratio -0.72 -0.53 -2.15 -18.12 -1.8 -1.14K
P/OCF Ratio -0.73 -0.59 -2.42 -26.62 -1.92 -1.18K
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.03 0.04 0.04 0.08 0.00 n/a
Quick Ratio 8.57 10.67 14.63 11.19 26.59 10.40
Current Ratio 8.57 10.93 14.90 11.30 26.72 10.40
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.49 -0.36 -0.21 -0.18 -0.14 -0.54
Return on Assets (ROA) -0.43 -0.32 -0.19 -0.15 -0.13 -0.49
Return on Capital (ROIC) -0.52 -0.39 -0.22 -0.17 -0.14 -0.54
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a